Anytime you can reduce dexamethasone (dex), do it There was one specific trial that was presented at this year’s ASH that studied the benefit of dex. The study was conducted with 199 intermediate fit patients with Revlimid and dexamethasone (Rd) induction (9 cycles) and Revlimid (R) maintenance until progression compared to Rd induction and Rd […]
I am looking forward to shedding my puffy winter jacket and traveling to sunny San Diego to attend the 60th Annual Meeting of the American Society of Hematology (#ASH18) with the International Myeloma Foundation (IMF). This will be the seventh time I have attended ASH, but going to this meeting never gets old. I anxiously […]
As Mary Lamia, a clinical psychologist, says “Hope structures your life in anticipation of the future and influences how you feel in the present. There is no question that today there is great cause for hope in the treatment of Multiple Myeloma (MM). It is with this hope I am excited to be attending ASH […]
